Day: 9 3 月, 2025

- The Hong Kong International Jewellery Show drew to a successful close yesterday while the Hong Kong International Diamond, Gem & Pearl Show ended on Thursday- The twin shows attracted over 82,000 buyers from 141 countries and regions, illustrating Hong Kong’s international influence as a trading platform for the industry- There was an increase in the number of buyers from ASEAN, Middle East, Western Europe and North America.- An on-site survey revealed that buyers and exhibitors considered the Middle East market to hold the greatest potential for growth in the jewellery industry over the next two years- Over 40% of respondents expected overall sales to increase in the next one to two years, with more than 50% anticipating stabilityHONG KONG, Mar 9, 2025 - (ACN Newswire via SeaPRwire.com) - The 41st Hong Kong International Jewellery Show and 11th Hong Kong International Diamond, Gem & Pearl Show, organised by the Hong Kong Trade Development Council (HKTDC), attracted some 4,000 exhibitors from more than 40 countries and regions, running in the successful “two shows, two venues” format. The Jewellery Show concluded at the Hong Kong Convention and Exhibition Centre (HKCEC) yesterday while the Diamond, Gem & Pearl Show closed at AsiaWorld-Expo on Thursday. This year’s International Jewellery Show introduced the Gold Jewellery zone, showcasing unique designs and exquisitely crafted gold jewellery, and the Young Jewellery Designer Arena, highlighting the potential of emerging designers, helping the industry to capture new opportunities.The twin jewellery shows attracted over 82,000 buyers from 141 countries and regions. Among them, some 32,000 buyers from 125 countries and regions participated in the Diamond, Gem & Pearl Show, while about 51,000 buyers from 133 countries and regions attended the International Jewellery Show. There was an increase in the number of buyers from ASEAN, the Middle East, Western Europe and North America, highlighting the international appeal of the shows.Sophia Chong, Deputy Executive Director of the HKTDC, said: “As a leading global trading hub for the jewellery industry, the twin jewellery shows brought together international buyers and organised more than 30 industry seminars and activities to foster innovation and collaboration within the sector. The shows also actively promote local design and nurture the next generation of industry talents through jewellery design competitions, underscoring their impact on the global jewellery landscape and reinforcing Hong Kong's status as a world-class convention and exhibition centre."Exhibitors and buyers are most optimistic about the Middle East marketTo gain deeper insights into current and upcoming trends in the jewellery industry, the HKTDC conducted a survey among 1,434 exhibitors and buyers on-site. The results revealed that buyers and exhibitors are cautiously optimistic on the industry outlook. Key findings from the survey are as follows:Market and industry outlook 44.2% of respondents expected overall sales to increase in the next one to two years, with 50.6% anticipating stability.Respondents considered the growth prospects for jewellery products in the following target sales markets to be optimistic and very optimistic in the next two years: Middle East (76.8%), India (72.6%), Australia and Pacific Islands (67.8%), ASEAN (66.2%) and Korea (66.0%).In terms of market potential, the top markets most respondents wished to enter or develop were Europe (24.9%), ASEAN (15.2%), North America (13.4%), Middle East (11.4%) and Japan (7.9%).Looking ahead for the next three years, technological advancements in artificial intelligence (62.8%), big data (46.9%) and social media (44.6%) were anticipated to have the greatest impact on the jewellery industry.Product trendsRespondents believed that trendy fashion jewellery (61.9%), precious jewellery (39.1%) and demi fine jewellery (24.4%) have the greatest growth potential this year.Karat yellow gold (43.4%), karat white gold (37.8%) and pure gold (28.6%) will be the most popular precious metal products in 2025.Diamond (47.6%) will be the most in-demand gemstone, followed by ruby (26.2%) and emerald (19.1%).Echoing measures in the latest Government Budget, the twin jewellery shows continue exploring ways to facilitate local businesses expanding into the Mainland Chinese market and to seize e-commerce opportunities. This year, mainland e-commerce platforms Taobao and Tmall joined the International Jewellery Show the first time, helping exhibitors to enter the mainland market via live e-commerce. With 10 exhibitors and six KOLs participating, the event achieved a total reach of over 6 million people and generated sales of more than HK$50 million.Exhibitors reported sales exceeded expectationsThe twin jewellery shows are widely respected by the global industry, with happy exhibitors reporting that their sales exceeded expectations in 2025. Bringing together nine designers at the International Jewellery Show, the chairman of the Asia Jewelry Culture Design and Crafts Association in Hong Kong, Gigi Cheng, said: “We hope to connect with buyers from the Middle East through the show and explore new international markets, aiming for sales of US$1 million to $3 million.” Hong Kong exhibitor Hatta Chang, Chairman of Hatta New Company, stated that the company successfully connected to buyers from Russia, Korea and Mainland China with sales tripling compared to last year. At the Hong Kong International Diamond, Gem & Pearl Show, Carl Philip Arnoldi, CEO of German exhibitor HC Arnoldi e.K, said: “One of the show’s biggest advantages is its ability to attract manufacturers and buyers from around the globe. On the first day, we received many buyers from the Middle East and Asia. We anticipate a sales growth of 20% to 50% this year.” Another exhibitor pointed out that the shows not only connected them with major retailers in the United States, but also potential partners in emerging markets such as Indonesia, the Philippines, Vietnam, and more. He also met a lot of return buyers sourcing at the shows.Additionally, buyers from Mainland China, the Middle East, the United States and Malaysia anticipated to invest sums of up to US$1 million in sourcing at the twin jewellery shows. At the International Jewellery Show, Hunan Caidu Jewelry Trading Co., Ltd from Mainland China placed an order of more than US$400,000 for high-quality pearls from Australia. Kanz Jewels LLC from the UAE budgeted to place an order worth US$250,000. Lebanese buyer Michel Zoughaib praised the show as a one-stop platform for sourcing products with different designs, as well as jewellery technology and packaging. He came with a budget of US$1 million but, “If I can find the right supplier, I can spend up to US$15 million,” he said.David Levy, President of David Levy Diamond Inc. in the United States, stated that the shows not only enabled connections with manufacturers but also provided access to different types of businesses within the supply chain. He believed that by attending the Hong Kong twin jewellery shows, he could find everything he needed. “I expect to spend US$200,000 at the Diamond, Gem & Pearl Show and at least US$250,000 at the Jewellery Show,” he said. The sourcing dynamic of buyers from the ASEAN market was noticeably vibrant, with Tomei Gold and Jewelry Manufacturing SDN BHD from Malaysia saying it had allocated a procurement budget of US$100,000 to $200,000.Enhancing support for a Muslim-friendly sourcing experienceThis year, special measures were introduced to encourage more Muslim buyers to visit the shows, including providing prayer rooms in venues, running shuttle buses to and from local mosques, offering a list of Muslim-friendly hotels and restaurants, and cooperating with the Hong Kong Tourism Board to arrange guided tours.As a globally leading one-stop jewellery industry sourcing platform, this year's twin jewellery shows continue to adopt the EXHIBITION+ online and offline hybrid format, enabling enterprises to extend their physical exhibition negotiations to online matching platforms. The HKTDC’s AI-powered Click2Match provided online business matching for exhibitors and buyers, while buyers were able to use Scan2Match to scan exhibitors’ QR codes and continue discussions with exhibitors online during or after the show. Buyers could enhance their efficiency by completing registration and buyer verification in advance through the HKTDC Marketplace App and the official show websites.Photo download: https://bit.ly/3XyhcAcOrganised by the HKTDC, the 41st Hong Kong International Jewellery Show and 11th Hong Kong International Diamond, Gem & Pearl Show have concluded successfullyThe twin jewellery shows are widely respected by the global industry and the sourcing dynamic of buyers was noticeably vibrant this yearSalina Yan, Permanent Secretary for Financial Services and the Treasury (Financial Services) of the Hong Kong SAR Government (fifth right), was Guest of Honour at the jewellery networking reception to welcome representatives and buyers from both local and international sectors with the goal of enhancing collaboration and fostering exchange within the industryThe jewellery parades showcased cutting-edge creative designs and enhanced interaction among industry stakeholdersThe participation of Taobao and Tmall at the International Jewellery Show helped exhibitors to broaden their reach in the Mainland China marketThe International Jewellery Show introduced the Gold Jewellery zone this year, showcasing innovatively designed gold jewelleryThe twin jewellery shows featured 38 pavilions with the Asia Jewellery Culture Design and Crafts Association Limited participating for the first time. In addition, the Young Jewellery Designer Arena was unveiled at this year’s International Jewellery Show, highlighting the creativity and craftsmanship of up-and-coming designersOver 30 industry seminars and networking events were held during the twin jewellery showsWebsites Hong Kong International Jewellery ShowHong Kong International Diamond, Gem & Pearl ShowWebsitehttps://www.hktdc.com/event/hkjewellery/enhttps://www.hktdc.com/event/hkdgp/enSelected productshttps://bit.ly/4hE1ifzHKTDC Media Room: https://mediaroom.hktdc.com/enMedia enquiriesPlease contact HKTDC’s Communication & Public Affairs Department: Sharon HaTel: (852) 2584 4575Email: sharon.mt.ha@hktdc.orgSerena CheungTel: (852) 2584 4272Email: serena.hm.cheung@hktdc.orgClayton LauwTel: (852) 2584 4472Email: clayton.y.lawuw@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. Copyright 2025 ACN Newswire via SeaPRwire.com.

Results Highlights:- Revenue hit record high of US$164.1 million, up 6.6% year-on-year.- Sales volume reached 1.7 million units, of which 1.5 million units were proprietary products, showing an increase of 4.8% year-on-year.- Gross profit increased by 7.5% to US$114.5 million, with gross profit margin improving to 69.8%; profit for the year attributable to owners of the Company was US$39.7 million.- The Board proposed a final dividend of HK10 cents per share, representing a dividend payout ratio of 26.7%.- The Group maintained a sound financial position with cash and bank balances of US$248.6 million at year-end to support merger and acquisition initiatives.- Fueled by newly acquired distributors in Indonesia and South Korea, along with organic growth in direct sales, APAC market revenue grew 43.7% year-on-year, while the US and the PRC markets showed signs of recovery in the second half of 2024.- The Group registered products of eucatech AG, a German company acquired in November 2023, in the Czech Republic, Italy, Malaysia, Saudi Arabia, Spain, Switzerland, UAE, and Vietnam.HONG KONG, Mar 7, 2025 - (ACN Newswire via SeaPRwire.com) - OrbusNeich Medical Group Holdings Limited (“OrbusNeich” or the “Group”; stock code: 6929), a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (“PCI”) and percutaneous transluminal angioplasty (“PTA”) procedures, today announced its annual results for the year ended December 31, 2024 (the “Year”), reporting record-high revenue and healthy net profit despite the challenging business landscape.Driven by the recovery of sales in the US and continued growth in the APAC market in the second half of the year, the Group’s revenue reached US$164.1 million, an increase of 6.6% over the previous year. Excluding the impact of foreign exchange, revenue growth would have been 8.7% year-on-year. Gross profit increased by 7.5% to US$114.5 million, and gross profit margin rose slightly to 69.8%. During the Year, the Group laid the groundwork for stronger long-term performance by integrating the businesses of the three companies acquired in late 2023. Although these integration efforts incurred temporary costs, resulting in a profit of US$39.7 million attributable to the owners of the Company (2023: US$45.1 million), they are expected to generate substantial synergies in the future. Excluding the abovementioned additional expenses, the three core operating expenses, namely selling and distribution expenses, general and administrative expenses and research and development expenses, were remained stable year-on-year.As of December 31, 2024, the Group was in a strong financial position with cash and bank balances amounting to US$248.6 million (2023: US$255.8 million). After careful consideration of the Group’s future capital requirements, the Board has proposed a final cash dividend of HK10 cents per share (2023: HK10 cents per share) as a token of appreciation for the continued support from shareholders and investors.Mr. David Chien, Chairman, Executive Director and Chief Executive Officer of OrbusNeich, said, “In 2024, the OrbusNeich team navigated challenges while diligently strengthening R&D, production, supply chain, clinical, regulatory, quality, sales, and marketing capabilities. The immediate contributions of our newly acquired distributors in Indonesia and South Korea bolstered our APAC market performance. Meanwhile, our focus on product registration for eucatech AG, has resulted in approvals in eight countries, with more on the horizon. As we celebrate OrbusNeich’s 25th anniversary in 2025, our relentless innovation, strong global presence and pioneering products will continue to propel us to new heights, as evidenced by our established global reputation and continued revenue growth over the past few years. Looking ahead, we remain committed to improving patient outcomes while striving to create long-term value for shareholders.”Extensive Sales Network Fuels Growth in APAC and EMEAOrbusNeich sold its products through its extensive sales network covering more than 70 countries and regions worldwide, and maintained a balanced revenue distribution across major markets. Driven by external growth from newly acquired distributors in Indonesia and South Korea, as well as robust organic growth from the markets in Malaysia, Singapore, Hong Kong, Vietnam, and India, the APAC market became the Group’s major growth driver during the Year, with revenue increasing by 43.7% to US$52.2 million. In particular, the latest generation of scoring balloon, Scoreflex TRIO, recorded rapid sales growth following its launch in Malaysia in early 2024. EMEA market revenue grew by 7.9% year-on-year to $39.2 million, mainly attributable to increased sales of the Group’s proprietary balloon products in direct sales markets such as Germany and Spain, as well as in distribution markets such as the Czech Republic, Slovakia, and the United Kingdom.Both the PRC and the US markets achieved significant improvement in the second half of 2024. As the Beijing-Tianjin-Hebei “3+N” Alliance Volume-Based Procurement (“VBP”) was gradually rolled out in various provinces, the Group adopted a more proactive marketing strategy, which resulted in Scoreflex’s sales volume gaining momentum, facilitating an improvement in the performance of the PRC market in the second half of the year, reaching a revenue of US$20.7 million. Meanwhile, following active discussions with Abbott, the Group’s US distributor, revenue in the US gradually picked up. In particular, the sales volume of the high selling price product, Scoreflex NC, more than tripled in the second half of the year compared with the first half, driving the revenue of the US market to reach US$17.5 million. The Japan market recorded revenue of US34.4 million.Diversity in Innovation with a Portfolio of Approved Products and Upcoming Clinical TrialsAs of December 31, 2024, OrbusNeich had more than 240 granted patents and published patent applications worldwide in key jurisdictions and an aggregate of more than 50 approved products. During 2024, the Group made significant progress in terms of product registrations and clinical trials, including:- Obtained NMPA approval for Teleport Neuro, FDA approval for Teleport XT, JADE PLUS 14/18/35 OTW, Sapphire Ultra and Sapphire NC Ultra, and CE Marks for Sapphire Ultra, Sapphire NC Ultra, Xtenza and Teleport XT;- Submitted NMPA registration application for its guiding catheter and Jade PTA Line Extension, and PMDA registration application for Scoreflex QUAD and Teleport Glide;- Completed clinical trial patient enrollment for Scoreflex TRIO in the PRC with NMPA application submission in January 2025;- Initiated clinical trial patient enrollment for Sapphire 3 in the US in Q4 2024, with approval application expected to submitted in Q1 2026.The Group has also been actively registering eucaLimus (DES), Support C (coronary DCB), and VITUS (peripheral DCB) in various countries following the acquisition of eucatech AG in late 2023. Registrations for one or more of the above-mentioned products were completed in the Czech Republic, Italy, Malaysia, SaudiArabia, Spain, Switzerland, the UAE, and Vietnam, while applications are pending approval in Hong Kong, Indonesia, and Singapore. Additionally, to renew the CE Mark for its products under the MDR regime, clinical registries have been initiated with renowned key opinion leader clinicians as lead principal investigators.The Group continued to invest in new pipeline products such as the aspiration catheter, dual lumen catheter, peripheral scoring balloon and sheath, and registration of these products is expected to be submitted to various regulatory bodies in 2025. In line with the “leave nothing behind” trend, the Group is also investing in proprietary paclitaxel DCB, with clinical trials expected to commence in the fourth quarter of 2025 in Japan.During the year, the joint venture OrbusNeich P&F made significant efforts to advance the clinical studies of TricValve in two major APAC markets. The clinical trial in the PRC started in April 2024, while the PMDA clinical trial protocol approval in Japan is expected to be completed by the end of 2025.In addition to proprietary products, the Group also entered into a distribution agreement with a Chinese manufacturer to distribute its intravascular ultrasound (IVUS) catheter in Hong Kong and Macau from December 2024, thereby diversifying its product offerings.Exceptional Product Quality Ensured through Stringent Production ProcessesAs of December 2024, OrbusNeich’s annual production capacity reached approximately 2.0 million units of balloons and 60,000 units of stents, with product quality ensured by a strict management system and maintaining ISO 13485 certification. Notably, eucatech AG successfully passed its ISO 13485 re-certification audit in the latter half of 2024, while the Shenzhen site achieved ISO 14001 and ISO 45001 certifications in June 2024, highlighting its commitment to sustainability.In addition, the construction of the Group’s largest R&D and production facility in Hangzhou, PRC, progressed smoothly during the Year. The Group is currently focusing on enhancing its automation levels to reduce labor requirements, improve operational efficiency, and ultimately lower overall operating costs. The facility is expected to be operational in 2027 and will add an annual production capacity of 2.4 million units upon the commencement of production.Mr. Chien concluded, “Entering 2025, we are cautiously optimistic about our prospects given the strong growth momentum in APAC and EMEA, as well as the recovering US and PRC markets. Over the past 25 years, our success has been fueled by continuous innovation, product line expansion and a strengthened sales network. These efforts, together with the synergies from the integration of our acquired businesses, will position us well to capitalize on the opportunities that lie ahead. With robust financial resources, we are able to take advantage of industry consolidation for strategic mergers and acquisitions to enhance our technological reserves and expand our product portfolio. To maintain our steady growth in the medical device market, we will place greater emphasis on sustainable development to adapt to the evolving healthcare landscape while staying true to our mission of improving patient outcomes.”About OrbusNeich Medical Group Holdings LimitedOrbusNeich is a major global medical device manufacturer specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, our Group sells its products in more than 70 countries and regions worldwide. It is also actively expanding into neuro vascular intervention and structural heart disease. With an in-house R&D team boasting over 20 years of product development expertise, our Group has developed world-leading proprietary technologies.For more information, please visit the Group’s official website: https://orbusneich.com/. Copyright 2025 ACN Newswire via SeaPRwire.com.